In addition to the rich microenvironment of the bone tissue, the abundantly secreted RANKL can also attract RANK-expressing circulating breast cancer cells to migrate into bone matrix, apart from the C-X-C chemokine receptor type (CXCR) 4/12 interaction. The gene discussed is TNFRSF11A; the disease is breast carcinoma.